Epidemiology and Outcomes Associated with PR Prolongation
Larry R Jackson1, Francis Ugowe2
1Duke University Medical Center, DUMC Box 3860, 2301 Erwin Road, Durham, NC 27710, USA.
Cardiac Electrophysiology Clinics
|October 25, 2021
Summary
PR prolongation, a delay in heart
Area of Science:
- Cardiology
- Electrophysiology
- Medical Research
Background:
- PR prolongation signifies delayed electrical conduction within the heart's system.
- Its prevalence increases with age and in patients with heart disease.
Purpose of the Study:
- To review the definition, prevalence, and clinical implications of PR prolongation.
- To highlight the association of PR prolongation with adverse cardiovascular outcomes.
Main Methods:
- Literature review of contemporary studies on PR prolongation.
- Analysis of prevalence data across different age groups and patient populations.
Main Results:
- PR prolongation is linked to a higher risk of atrial arrhythmias, heart failure, and mortality.
- Prevalence is low in younger individuals but rises significantly after age 60.
Conclusions:
- PR prolongation is an important indicator of cardiovascular risk.
- Further research is needed for precise risk stratification in elderly patients.
More Related Videos
10:05Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
8.5K
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
307
Related Concept Videos
01:27Pulmonary Embolism III: Nursing Management
78
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
78
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
278
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
278
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
71
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
71
01:29Pulmonary Embolism I: Introduction
186
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
186
01:19Mitral Valve Prolapse III: Nursing Management
56
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
56
01:08Prevalence and Incidence
949
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
949